Contact
Please use this form to send email to PR contact of this press release:
Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia
TO:
Please use this form to send email to PR contact of this press release:
Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia
TO: